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Abstract
Background: Odontogenic necrotizing fasciitis of the neck is a fulminant infection of odontogenic origin that
quickly spreads along the fascial planes and results in necrosis of the affected tissues. It is usually polymicrobial,
occurs frequently in immunocompromised patients, and has a high mortality rate.
Case presentation: A 69-year old Mexican male had a pain in the maxillar right-canine region and a swelling of
the submental and submandibular regions. Our examination revealed local pain, tachycardia, hyperthermia (39°C),
and the swelling of bilateral submental and submandibular regions, which also were erythematous, hyperthermic,
crepitant, and with a positive Godet sign. Mobility and third-degree caries were seen in the right mandibular
canine. Bacteriological cultures isolated streptococcus pyogenes and staphylococcus aureus. The histopathological
diagnosis was odontogenic necrotizing fasciitis of the submental and submandibular regions. The initial treatment
was surgical debridement and the administration of antibiotics. After cultures were negative, the surgical wound
was treated with a growth factor-enriched autologous plasma eight times every third day until complete healing
occurred.
Conclusions: The treatment with a growth factor-enriched autologous plasma caused a rapid healing of an
extensive surgical wound in a patient with odontogenic necrotizing fasciitis. The benefits were rapid tissue
regeneration, an aesthetic and a functional scar, and the avoidance of further surgery and possible complications.
Introduction
Cervical necrotizing fasciitis (CNF) is an uncommon,
rapidly progressive, and potentially lethal infection com-
prising skin, subcutaneous tissue, superficial fascia, and
occasionally the deep fascia. Its rapid progression results
in necrosis and severe systemic toxicity. The incidence
of CNF is 2.6% out of the infections of head and neck
[1]. Clinical manifestations include pain and local
erythema. The skin turns dark with purple dots. The
pressure on the zone reveals gas accumulated by the
excessive metabolism of bacteria. In advanced stages,
thrombosis of local blood vessels of the skin and
subcutaneous tissue leads to necrosis and later to gang-
rene. This infectious pathology is common in people
who use drugs and/or alcohol, people with diabetes,
immunocompromised individuals, and patients with
pressure ulcers. The conventional management consists
of a vigorous debridement of necrotized skin, subcuta-
neous tissue, all fascias, and muscle, along with specific
antimicrobial treatment. Once the affected area is free
from any infection, the surgical defect is treated using
restorative plastic surgery that involves the rotation of a
pedicle or a skin graft [2].
Growth factors (GFs) are biomolecules that regulate a
great variety of key functions in the body, including
mitosis, cell differentiation, extracellular matrix synth-
esis, and metabolism. During the ontogeny, some GFs
also display chemotactic activity to direct cell migration.
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where they play a protective role against the natural and
pathologic cell death. Generally, the production and the
physiological activity of GFs occur at low concentration
(picomolar, pM) in a wide variety of cells. All these
advantages have supported the use of GFs in different
medical procedures. Several GFs can be obtained at dif-
ferent concentrations from peripheral blood to provide
their biological actions on a particular tissue or organ
with a lesion. In wound healing, GFs significantly
decrease the time of tissue regeneration [3] and scarring
by improving cell metabolism, causing protein synthesis,
and promoting cell proliferation [4].
In this work, we report the effectiveness of GF-
enriched autologous plasma to promote rapid and func-
tional healing of an extensive surgical wound resulting
from the aggressive surgical debridement in a patient
with odontogenic necrotizing fasciitis. Because the
wound comprised the submental and submandibular
regions, the main goal was to provide an aesthetic and
functional scar in the neck, thus avoiding secondary
reconstructive plastic surgery and further complications.
Case Report
A 69-year-old Mexican male (Figure 1 panel A) was
referred to the Maxillofacial Surgery Department of the
“Hospital Regional Primero de Octubre (ISSSTE)” in
Mexico City. The patient had pain in the maxillar right-
canine region and a three-day swelling of the submental
and submandibular regions. The clinical examination
showed pain during palpation, tachycardia, and
hyperthermia (39°C). The bilateral submental and sub-
mandibular regions had a 10-cm diameter swelling and
well-delimitated erythematous, hyperthermia, crepitant
sound, and a positive Godet sign. After a three-hour
evolution, a blister surrounded by a 4-cm diameter
necrotic area could be detected (Figure 1 panel B). After
an eight-hour evolution, the original diameter of the
necrotic area had doubled (Figure 1 panel C). An
intraoral examination showed mobility and third-degree
caries of the mandibular right canine. The patient had a
history of diabetes mellitus type II, moderate malnutri-
tion, chronic alcoholism, and hepatic disease. Laboratory
studies provided the following relevant results: hemoglo-
bin, 11.1 g/dL; hematocrit, 31.4%; leukocytes, 15 × 10
3/
dL of blood, whose differential count was as follows,
(neutrophils, 12.72 × 10
3; lymphocytes, 0.85 × 10
3;
monocytes, 0.83 × 10
3; eosinophils, 0.45 × 10
3;b a s o -
phils, 0.14 × 10
3; platelets, 78 × 10
3); glycemia, 185 mg/
dL; calcium, 6.49 mg/dL; phosphorus, 2.68 mg/dL; crea-
tinine, 0.76 mg/dL; total protein, 5.2 mg/dL; albumin,
2.4 mg/dL; total bilirubin, 7.3 mg/dL; prothrombin time
(PT), 17.2 sec. A bacteriological culture isolated strepto-
coccus pyogenes and staphylococcus aureus.T h ef i n a l
diagnosis was odontogenic necrotizing fasciitis of the
submental and submandibular regions, which was corro-
borated by a trans-surgical biopsy of the affected area.
Aggressive surgical debridement was made 8 hours and
24 hours after the patient’s admission. Both submandibu-
lar glandules and the suprahyoideus and infrahyoideus
muscles were exposed. At this time, the dimensions of
the postsurgical wound were 10.5 × 7.3 cm (area =
76.7 cm
2). The antibiotics administered were ceftriaxone
(2 g, IV, every 24 h), clindamycin (600 mg, IV, every
6 h), and amikacin (500 mg, IV, every 12 h). Consecutive
bacteriological cultures were made until the results were
negative. The decision for the treatment of the surgical
wound with GF-enriched autologous plasma to promote
Figure 1 Male patient with an odontogenic necrotizing fasciitis. A) Necrotic area after emergency room admission, B) Necrotic area after
three-hour evolution. C) Necrotic area after eight-hour evolution.
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condition of the patient (diabetes, liver failure, normocy-
tic anemia, hypocalcaemia, malnutrition, hyperbilirubine-
mia, decompensate respiratory alkalosis, and confusional
syndrome).
The GF-enriched plasma was obtained from 15 mL
of the patient’s peripheral blood as described elsewere
[5,6]. This volume was divided equally into 5 sterile
tubes containing 0.5 mL of 3.8% sodium citrate as an
anticoagulant. After centrifugation at 1800 rpm for
8 minutes at room temperature, the plasma had
divided into three fractions of about equal volume.
The upper fraction is plasma poor in GFs, the middle
fraction is plasma with a medium concentration of
GFs, and the lower portion is plasma rich in platelets
and GFs [7]. The lower portion was collected from all
5 tubes and pooled into one sterile tube. To induce
platelet degranulation, fifty μL of 10% CaCl2 solution
was added for each mL of platelets and GFs enriched
plasma and the mixture was gently stirred to allow it
to gel [8,9]. Finally, a total volume of 2 × mL of the
gel fraction containing GF-enriched plasma, with pink-
yellow color, was separated from the fraction of plate-
let rich plasma (translucent color) [3]. Approximately
1.5 mL of the gel fraction was directly applied in the
center of the wound and then manually spread to
cover the total area of the surgical wound. This proce-
dure was repeated every third day until the completion
of the wound healing (Figure 2). The local application
of GF-enriched autologous plasma caused tissue repair
in a considerably reduced time (Figure 3). The non-
linear analysis of the temporal course of wound healing
determined the concentric regeneration period was
within weeks 0 to 3 and the healing process period
was within weeks 4 to 6. A mixed period of regenera-
tion and healing extended from 15 to 25 days. The
time required to achieve 50% closing of the surgical
wound was 12 days and the total closure was reached
at week 6 after the onset of the GF-enriched auto-
logous plasma treatment (Figure 3).
Discussion
This study shows for the first time the advantages of the
topical use of GF-enriched autologous plasma on an
extensive surgical wound in the neck of a patient with
odontogenic necrotizing fasciitis caused by streptococcus
pyogenes and staphylococcus aureus. Our treatment
avoided the formation of a function-limiting scar, one of
the most frequent complications following an aggressive
surgical debridement of necrotized tissues in the neck.
Remarkably, the rapid and physiological healing of the
surgical wound avoided further reconstructive plastic
surgery, which involves pedicled graft rotation and sec-
ondary facial deformation.
The occurrence of necrotizing fasciitis remains an
extremely uncommon condition with a limited number
of cases reported in the literature. The lack of medical
experience makes the diagnosis difficult, which allows
the infection to rapidly spread to skin, subcutaneous tis-
sue, superficial fascia, and occasionally the deep fascia,
ending up in severe necrosis and systemic toxicity [2].
The prognosis depends on an early diagnosis, nutritional
support, effective wide-spectrum antibiotics, and an
aggressive surgical debridement along with several surgi-
cal washes every 24 to 48 hours until bacteriological cul-
tures are negative [10]. Our therapy with repeated
topical application of GF-enriched autologous plasma on
the surgical wound improved the prognosis of a patient
with odontogenic necrotizing fasciitis. Our clinical
experience surely will be useful in establishing a routine
treatment for sterile wounds requiring rapid and physio-
logical healing.
Other clinical reports show the efficiency of GF-
enriched autologous plasma in healing wounds from dif-
ferent origins. We propose it as an alternative therapy
to provide tissular regeneration of skin, bone, and mus-
cle [11-13]. Although effective for tissular regeneration,
the therapeutic use GF-enriched autologous plasma is
still controversial because its preparation does not con-
sistently provide the same type and concentration of
GFs [7]. An initial characterization of GF-enriched auto-
logous plasma shows the presence of platelet-derived
growth factor (PDGF), transforming growth factor-ß1
(TGF-ß1), basic fibroblast growth factor (bFGF), vascu-
lar-endothelial growth factor (VEGF), epidermal growth
factor (EGF), and insulin-like growth factor type I (IGF-
I). All these GFs are involved in skin regeneration and
scarring, because all together stimulate cell mitosis and
differentiation, promote angiogenesis, granulation tissue
formation, re-epithelialization, and stimulate extracellu-
lar matrix and collagen synthesis. Nevertheless, the con-
centration of GFs in the gel of GF-enriched autologous
plasma is variable and depends on the general condi-
tions of the patient, especially the nutritional and immu-
nological state. This is why the therapy was the repeated
topical application until the complete healing of the
wound is achieved. Despite thrombocytopenia of the
patient, the procedure to obtain GF enriched autologous
plasma was very effective to provide the concentrations
of GFs required to activate their receptors and exert
their trophic effects. The ability of GF’s to activate their
receptors at low concentrations, in the range of picomo-
lar (pM) to nanomolar (nM) [14] can account for the
therapeutic effect. Even though we ignored the type and
exact concentration of GFs released from the gel of GF-
enriched autologous plasma, it is unquestionable that
our therapeutic scheme provided effective concentra-
tions of GFs. The photographic sequences (Figure 2)
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course of the concentric regeneration and healing pro-
cesses demonstrate the success of our therapy. The
functional and neuropsychological restoration allowed
the patient to promptly return to a normal family and
social life.
Conclusions
The gel of GF-enriched autologous plasma provided an
aesthetic and functional scar in the neck that allowed
the patient to recover his normal life in a relatively
short time after treatment. The optimum neuropsycho-
logical adaptation avoided the use of further reconstruc-
tive plastic surgery and the possible development of
unnecessary complications. On this basis, we propose
the topical use of GF-enriched autologous plasma as a
coadjuvant procedure in the management of patients
with necrotizing fasciitis.
Patient’s perspective
Before the beginning of my father’s treatment, photo-
graphs of other people with the same disease and
Figure 2 Photographic sequence of results after GF-enriched autologous plasma application. The photographs show the progressive
decrease of the surgical defect until the entire healing of the wound. A) Surgical wound with negative bacteriological culture. B) Application of
polymerized GF-enriched autologous plasma. C-H) Temporal course of surgical wound healing from the week 1 to the week 6. I) Aesthetic and
functional scar at the end of the week 7.
Figure 3 Temporal course of surgical wound healing evaluated
by the remaining debrided area. The black circles are the
measurement of the wound area. The continuous line was the
curve fit using nonlinear regression analysis of the GraphPad Prism
5.0 statistical package (GraphPad Software Inc., La Jolla, CA, USA).
EC50 is the time required to obtain 50% healing of the wound. R
2 is
the coefficient of determination.
Lopez-Fernandez et al. Journal of Medical Case Reports 2011, 5:98
http://www.jmedicalcasereports.com/content/5/1/98
Page 4 of 5treated with conventional management were shown to
me. The photographed people looked deformed by the
surgery. Now, when I see my father completely recov-
ered and healthy, I think that the new treatment offered
to my father was the best, and I believe in the use of
this treatment for other patients with the same disease.
Consent
Written informed consent for publication of this case
report and accompanying images was obtained from the
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